Blog


Monday, September 30th 2024

Instagram and prostate cancer: using validated instruments to assess the quality of information on social media

Xu AJ, Myrie A, Taylor JI, Matulewicz R, Gao T, Pérez-Rosas V, Mihalcea R, Loeb S. “Instagram and prostate cancer: using validated instruments to assess the quality of information on social media.” Prostate Cancer Prostatic Diseases. 2021 Dec 1 epub. PMID: 34853412. Link: https://pubmed.ncbi.nlm.nih.gov/34853412/


Comment
Monday, September 30th 2024

Perspectives of Residency Applicants and Program Directors on the Role of Social Media in the 2021 Urology Residency Match

Heard JR, Wyant WA, Loeb S, Marcovich R, Dubin JM. “Perspectives of Residency Applicants and Program Directors on the Role of Social Media in the 2021 Urology Residency Match.” Urology. 2021 Oct epub. PMID: 34606880. Link: https://pubmed.ncbi.nlm.nih.gov/34606880/


Comment
Monday, September 30th 2024

Gaps in Public Awareness About BRCA and Genetic Testing in Prostate Cancer: Social Media Landscape Analysis

Loeb S, Massey P, Leader AE, Thakker S, Falge E, Taneja S, Byrne N, Rose M, Joy M, Walter D, Katz MS, Wong RL, Selvan P, Keith SW, Giri VN. “Gaps in Public Awareness About BRCA and Genetic Testing in Prostate Cancer: Social Media Landscape Analysis.” JMIR Cancer. 2021 Sep 20;7(3):e27063. PMID: 34542414. Link: https://pubmed.ncbi.nlm.nih.gov/34542414/


Comment
Monday, September 30th 2024

Leveraging Social Media as a Thermometer to Gauge Patient and Caregiver Concerns: COVID-19 and Prostate Cancer

Loeb S, Mihalcea R, Perez-Rosas V, Xu A, Taylor J, Byrne N, Walter D, Ness M, Robbins R, Zhang S, Killeen T, Natesan D, Borno HT. “Leveraging Social Media as a Thermometer to Gauge Patient and Caregiver Concerns: COVID-19 and Prostate Cancer.” European Urology Open Science 2021; 25: 1-4 Link: https://pubmed.ncbi.nlm.nih.gov/34337497/


Comment
Monday, September 30th 2024

Growth of the Twitter Presence of Academic Urology Training Programs and Its Catalysis by the COVID-19 Pandemic

Manning E, Calaway A, Dubin JM, Loeb S, Sindhani M, Kutikov A, Ponsky L, Mishra K, Bukavina L. “Growth of the Twitter Presence of Academic Urology Training Programs and Its Catalysis by the COVID-19 Pandemic.” European Urology. 2021 May 15: S0302-2838(21)00326-2. PMID: 34006446. Link: https://pubmed.ncbi.nlm.nih.gov/34006446/


Comment
Monday, September 30th 2024

TikTok and Prostate Cancer: Misinformation and Quality of Information using Validated Questionnaires

Xu AJ, Taylor J, Gao T, Mihalcea R, Perez-Rosas V, Loeb S. “TikTok and Prostate Cancer: Misinformation and Quality of Information using Validated Questionnaires.” BJU International 2021 Apr 2. PMID: 33811424 Link: https://pubmed.ncbi.nlm.nih.gov/33811424/


Comment
Monday, September 30th 2024

Cancer misinformation on social media

Loeb S, Langford AT, Bragg MA, Sherman R, Chan JM. “Cancer misinformation on social media.” CA Cancer J Clin. 2024 Jun 19. PMID: 38896503. Link: https://pubmed.ncbi.nlm.nih.gov/38896503/ This review paper summarizes the literature on cancer misinformation that is circulating on social media, its impact and potential mitigation strategies.


Comment
Monday, September 30th 2024

Assessment of Artificial Intelligence Chatbot Responses to Top Searched Queries About Cancer

Pan A, Musheyev D, Bockelman D, Loeb S, Kabarriti AE. “Assessment of Artificial Intelligence Chatbot Responses to Top Searched Queries About Cancer.” JAMA Oncology. 2023 Aug 24:e232947. Link: https://pubmed.ncbi.nlm.nih.gov/37615960/ We used 4 AI chatbots (ChatGPT, Perplexity, Chatsonic, Bing AI) for information about the top 5 cancers (skin, lung, breast, colorectal and prostate cancer). The quality… Read More


Comment
Monday, September 30th 2024

Plant-Based Diets and Disease Progression in Men With Prostate Cancer

Liu VN, Van Blarigan EL, Zhang L, Graff RE, Loeb S, Langlais CS, Cowan JE, Carroll PR, Chan JM, Kenfield SA. “Plant-Based Diets and Disease Progression in Men With Prostate Cancer.” JAMA Netw Open. 2024 May 1;7(5):e249053. Link: https://pubmed.ncbi.nlm.nih.gov/38691361/


Comment
Monday, September 30th 2024

Plant-based diet associated with better quality of life in prostate cancer survivors

Loeb S, Hua Q, Bauer SR, Kenfield SA, Morgans AK, Chan JM, Van Blarigan EL, Shreves AH, Mucci LA. “Plant-based diet associated with better quality of life in prostate cancer survivors.” Cancer 2024; 130: 1618. Link: https://pubmed.ncbi.nlm.nih.gov/38348508/


Comment
Monday, September 30th 2024

Unmet sexual health resource needs and preferences for interventions to address these needs among female partners of patients with prostate cancer

Gupta N, Zebib L, Wittmann D, Nelson CJ, Salter CA, Mulhall JP, Byrne N, Nolasco TS, Schofield E, Loeb S. “Unmet sexual health resource needs and preferences for interventions to address these needs among female partners of patients with prostate cancer.” Urology. 2023 Dec 29:S0090-4295(23)01109-3. Link: https://pubmed.ncbi.nlm.nih.gov/38160766/


Comment
Monday, September 30th 2024

Understanding the sexual health perceptions, concerns, and needs of female partners of prostate cancer survivors

Gupta N, Zebib L, Wittmann D, Nelson CJ, Salter CA, Mulhall JP, Byrne N, Nolasco TS, Loeb S. “Understanding the sexual health perceptions, concerns, and needs of female partners of prostate cancer survivors.” Journal of Sexual Medicine. 2023 Apr 27;20(5):651-660. Link: https://pubmed.ncbi.nlm.nih.gov/36941211/


Comment
Monday, September 30th 2024

Sleep disturbances are underappreciated in prostate cancer survivorship

Gong F, Loeb S, Siu K, Myrie A, Orstad S, Kenfield SA, Morgans A, Thakker S, Robbins R, Carter P, Jean-Louis G, Nolasco TS, Byrne N, Gupta N. “Sleep disturbances are underappreciated in prostate cancer survivorship.” Prostate Cancer Prostatic Disease 2023; 26: 210-212. Link: https://pubmed.ncbi.nlm.nih.gov/36543892/


Comment
Monday, September 30th 2024

Unmet Sexual Health Needs of Patients and Female Partners Following Diagnosis and Treatment for Prostate Cancer

Li R, Wittmann D, Nelson CJ, Salter CA, Mulhall JP, Byrne N, Nolasco TS, Ness M, Gupta N, Cassidy C, Crisostomo-Wynne T, Loeb S. “Unmet Sexual Health Needs of Patients and Female Partners Following Diagnosis and Treatment for Prostate Cancer.” J Sex Med. 2022 Oct 3:S1743-6095(22)01773-8. Link: https://pubmed.ncbi.nlm.nih.gov/36202730/


Comment
Monday, September 30th 2024

Poor sleep health and quality of life among caregivers of patients with prostate cancer

Thakker S, Robbins R, Carter P, Jean-Louis G, Siu K, Sanchez Nolasco T, Byrne N, Orstad SL, Myrie A, Loeb S. “Poor sleep health and quality of life among caregivers of patients with prostate cancer.” BJUI Compass. 2022 Jun 3;3(5):331-333. PMID: 35950040. Link: https://pubmed.ncbi.nlm.nih.gov/35950040/


Comment
Monday, September 30th 2024

Systematic review of sleep and sleep disorders among prostate cancer patients and caregivers: a call to action for using validated sleep assessments during prostate cancer care

Robbins R, Cole D O R, Ejikeme C, Orstad SL, Porten S, Salter CA, Sanchez Nolasco T, Vieira D, Loeb S. “Systematic review of sleep and sleep disorders among prostate cancer patients and caregivers: a call to action for using validated sleep assessments during prostate cancer care.” Sleep Med. 2022 Mar 31;94:38-53. PMID: 35489117. Link:… Read More


Comment
Monday, September 30th 2024

Development and Validation of a Survey to Assess Sexual Health in Female Partners of Patients with Prostate Cancer

Loeb S, Gupta N, Wittmann D, Nelson CJ, Mulhall JP, Salter CA, Byrne N, Sanchez Nolasco T, Zebib L, Garrett L, Schofield E. “Development and Validation of a Survey to Assess Sexual Health in Female Partners of Patients with Prostate Cancer.” Eur Urol Oncol. 2024 May 17:S2588-9311(24)00113-5. Link: https://pubmed.ncbi.nlm.nih.gov/38762369/ This paper reports on the development… Read More


Comment
Monday, September 30th 2024

Guidelines for Sexual Health Care for Prostate Cancer Patients: Recommendations of an International Panel

Wittmann D, Mehta A, McCaughan E, Faraday M, Duby A, Matthew A, Incrocci L, Burnett A, Nelson CJ, Elliott S, Koontz BF, Bober S, McLeod D, Capogrosso P, Yap T, Higano C, Loeb S, Capellari E, Glodé M, Goltz H, Howell D, Kirby M, Bennett N, Trost L, Odiyo Ouma P, Wang R, Salter C,… Read More


Comment
Monday, September 30th 2024

Interaction between race and prostate cancer treatment benefit in the Veterans Health Administration

Rude T, Walter D, Ciprut S, Kelly MD, Wang C, Fagerlin A, Langford AT, Lepor H, Becker DJ, Li H, Loeb S, Ravenell J, Leppert JT, Makarov DV. “Interaction between race and prostate cancer treatment benefit in the Veterans Health Administration.” Cancer. 2021 Jun 29 epub. PMID: 34184271. Link: https://pubmed.ncbi.nlm.nih.gov/34184271/


Comment
Monday, September 30th 2024

Prostate Cancer. Nature Reviews Disease Primers

Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, Gillessen S, Van der Kwast T, Bristow RG. “Prostate Cancer. Nature Reviews Disease Primers.” 2021 Feb 4;7(1):9. PMID: 33542230. Link: https://pubmed.ncbi.nlm.nih.gov/33542230/


Comment
Monday, September 30th 2024

The Lancet Commission on prostate cancer: planning for the surge in cases

James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, Trujillo B, Al-Lazikani B, Attard G, Bray F, Compérat E, Eeles R, Fatiregun O, Grist E, Halabi S, Haran Á, Herchenhorn D, Hofman MS, Jalloh M, Loeb S, MacNair A, Mahal B, Mendes L, Moghul M, Moore C, Morgans A, Morris M, Murphy… Read More


Comment
Monday, September 30th 2024

Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience

Gaylis FD, Cooperberg MR, Chen RC, Malin J, Loeb S, Witte JS, Carroll PR, Cohen ES, Dato PE, Lin DW, Zheng Y, Seibert TM, Setzler C, Wilt W, Gomez SL, Chan JML, Catalona WJ.  “Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience” Journal of Urology 2021 Apr 5. PMID: 33818133…. Read More


Comment
Monday, September 30th 2024

It Just Makes Sense to Me: A qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance for prostate cancer

Sutherland R, Gross CP, Ma X, Jeong F, Seibert TM, Cooperberg MR, Catalona WJ, Ellis SD, Loeb S, Schulman-Green D, Leapman MS.  “It Just Makes Sense to Me: A qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance for prostate cancer.” BJUI Compass. 2024 Apr 2;5(6):593-601. PMID: 38873351. Link: https://pubmed.ncbi.nlm.nih.gov/38873351/


Comment
Monday, September 30th 2024

PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer

Englman C, Maffei D, Allen C, Kirkham A, Albertsen P, Kasivisvanathan V, Baroni RH, Briganti A, De Visschere P, Dickinson L, Gómez Rivas J, Haider MA, Kesch C, Loeb S, Macura KJ, Margolis D, Mitra AM, Padhani AR, Panebianco V, Pinto PA, Ploussard G, Puech P, Purysko AS, Radtke JP, Rannikko A, Rastinehad A, Renard-Penna… Read More


Comment
Monday, September 30th 2024

Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer

Leapman MS, Sutherland R, Gross CP, Ma X, Seibert TM, Cooperberg MR, Catalona WJ, Loeb S, Schulman-Green D.  “Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer.” BJUI Compass. 2023 Aug 15;5(1):142-149. Link: https://pubmed.ncbi.nlm.nih.gov/38179031/


Comment
Monday, September 30th 2024

Barriers and enablers of active surveillance for prostate cancer – a qualitive study of clinicians

Pattenden TA, Thangasamy IA, Ong WL, Samaranayke D, Morton A, Murphy DG, Evans S, Millar J, Chalasani V, Rashid P, Winter M, Vela I, Pryor D, Mark S, Loeb S, Lawrentschuk N, Pritchard E.  “Barriers and enablers of active surveillance for prostate cancer – a qualitive study of clinicians.” BJU Int. 2023 Sep 11. Link:… Read More


Comment
Monday, September 30th 2024

Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation

Leapman MS, Wang R, Loeb S, Seibert TM, Gaylis FD, Lowentritt B, Brown GA, Chen R, Lin D, Witte J, Cooperberg MR, Catalona WJ, Gross CP, Ma X.  “Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation.” Journal of Urology. 2023 Apr;209(4):710-718. Link: https://pubmed.ncbi.nlm.nih.gov/36753746/


Comment
Monday, September 30th 2024

Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting

Moore CM, King LE, Withington J, Amin MB, Andrews M, Briers E, Chen RC, Chinegwundoh FI, Cooperberg MR, Crowe J, Finelli A, Fitch MI, Frydenberg M, Giganti F, Haider MA, Freeman J, Gallo J, Gibbs S, Henry A, James N, Kinsella N, Lam TBL, Lichty M, Loeb S, Mahal BA, Mastris K, Mitra AV, Merriel… Read More


Comment
Monday, September 30th 2024

A vision for closing the evidence-practice gap in the management of low-grade prostate cancer

Leapman MS, Loeb S, Cooperberg MR, Catalona WJ, Gaylis FD.  “A vision for closing the evidence-practice gap in the management of low-grade prostate cancer.” JNCI Cancer Spectrum. 2023 Mar 1;7(2):pkad028. Link: https://pubmed.ncbi.nlm.nih.gov/37101361/


Comment
Monday, September 30th 2024

Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression

Baboudjian M, Breda A, Rajwa P, Gallioli A, Gondran-Tellier B, Sanguedolce F, Verri P, Diana P, Territo A, Bastide C, Spratt DE, Loeb S, Tosoian JJ, Leapman MS, Palou J, Ploussard G.  “Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression.” Eur Urol Oncol. 2022 Aug 4:S2588-9311(22)00135-3. PMID: 35934625. Link: https://pubmed.ncbi.nlm.nih.gov/35934625/


Comment
Monday, September 30th 2024

Conservative Management of Low-Risk Prostate Cancer: A Path to Value-Based Care

Gaylis FD, Cooperberg MR, Loeb S, Chen RC, Seibert TM, Cohen E, Dato P, Emeka AA, Prime R, Romo S, Catalona WJ.  “Conservative Management of Low-Risk Prostate Cancer: A Path to Value-Based Care.” Urology Practice. 2022 May;9(3):195-197. Link: https://pubmed.ncbi.nlm.nih.gov/37145554/


Comment
Monday, September 30th 2024

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer

Press BH, Jones T, Olawoyin O, Lokeshwar SD, Rahman SN, Khajir G, Lin DW, Cooperberg MR, Loeb S, Darst BF, Zheng Y, Chen RC, Witte JS, Seibert TM, Catalona WJ, Leapman MS, Sprenkle PC.  “Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer.” Eur Urol Open Sci. 2022… Read More


Comment
Monday, September 30th 2024

Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment

Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, Eastham JA, Ehdaie B, Benfante N, Logothetis CJ, Gregg JR, Perez CA, Garza S, Kim J, Marks LS, Delfin M, Barsa D, Vesprini D, Klotz… Read More


Comment
Monday, September 30th 2024

Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study

Lowenstein LM, Choi NJ, Hoffman KE, Volk RJ, Loeb S.  “Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study.” BMJ Open. 2021 Nov 12;11(11):e048347. PMID: 34772748. Link: https://pubmed.ncbi.nlm.nih.gov/34772748/


Comment
Monday, September 30th 2024

Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness

Kang SK, Mali RD, Prabhu V, Ferket BS, Loeb S.  “Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.” Radiology. 2021 Sept;300(3):594-604. PMID: 34254851. Link: https://pubmed.ncbi.nlm.nih.gov/34254851/


Comment
Monday, September 30th 2024

Environmental Impact of Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Guided Prostate Biopsy

Leapman MS, Thiel CL, Gordon IO, Nolte AC, Perecman A, Loeb S, Overcash M, Sherman JD. “Environmental Impact of Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Guided Prostate Biopsy.” Eur Urol. 2023 Jan 10:S0302-2838(22)02857-3. Link: https://pubmed.ncbi.nlm.nih.gov/36635108/


Comment
Monday, September 30th 2024

Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer

Sundaresan VM, Wang R, Long JB, Sprenkle PC, Seibert TM, Loeb S, Cooperberg MR, Catalona WJ, Ma X, Gross CP, Leapman MS. “Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer.” Urology Practice. 2024 epub Jul 16. PMID: 39196719. Link: https://pubmed.ncbi.nlm.nih.gov/39196719/


Comment
Monday, September 30th 2024

Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile

Adorno Febles VR, Hao Y, Ahsan A, Wu J, Qian Y, Zhong H, Loeb S, Makarov DV, Lepor H, Wysock J, Taneja SS, Huang WC, Becker DJ, Balar AV, Melamed J, Deng FM, Ren Q, Kufe D, Wong KK, Adeegbe DO, Deng J, Wise DR. “Single-cell analysis of localized prostate cancer patients links high Gleason… Read More


Comment
Monday, September 30th 2024

Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer

Leapman MS, Sutherland R, Gross CP, Ma X, Seibert TM, Cooperberg MR, Catalona WJ, Loeb S, Schulman-Green D. “Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer.” BJUI Compass. 2023 Aug 15;5(1):142-149 Link: https://pubmed.ncbi.nlm.nih.gov/38179031/


Comment
Monday, September 30th 2024

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer

Press BH, Jones T, Olawoyin O, Lokeshwar SD, Rahman SN, Khajir G, Lin DW, Cooperberg MR, Loeb S, Darst BF, Zheng Y, Chen RC, Witte JS, Seibert TM, Catalona WJ, Leapman MS, Sprenkle PC. “Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer.” Eur Urol Open Sci. 2022… Read More


Comment